{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:16:57Z","timestamp":1791001017327,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["172102310388"],"award-info":[{"award-number":["172102310388"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012554","name":"Foundation for Distinguished Young Talents in Higher Education of Henan","doi-asserted-by":"publisher","award":["SB201902015"],"award-info":[{"award-number":["SB201902015"]}],"id":[{"id":"10.13039\/501100012554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the method and effectiveness of transcatheter arterial chemoembolization (TACE) combined with simultaneous DynaCT-guided Microwave ablation (MWA) for the treatment of small hepatocellular carcinoma (SHCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>From June 2015 to May 2017, a total of 28 consecutive patients with SHCC received single treatment of TACE and 23 subjects received a combination treatment of TACE with simultaneous DynaCT-guided MWA. Following 1\u2009month of treatment, the tumor response was assessed using the mRECIST criteria and the outcomes were analyzed including intervention-associated complications, changes in liver function, imaging response, and progression-free survival (PFS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The technical success rate was 100%. The rates of CR (65%) in the combined TACE and MWA group were higher than those of the TACE group (46%). The rate of common adverse events, such as liver abscess, spontaneous bacterial peritonitis and liver dysfunction, in the combined TACE and MWA group (56%) was comparable to the corresponding rate of the TACE group (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.411). The median and mean PFS of the TACE group were significantly lower than those of the combined TACE and MWA group (19.00\u2009months vs. 29.00\u2009months, 21.076\u2009months vs. 24.693\u2009months, <jats:italic>p<\/jats:italic>\u2009=\u20090.019, log-rank test).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Stereotactic DynaCT-guided MWA is a safe and effective method for the treatment of SHCC, which usually provides an effective tumor puncture path, notably for lesions that cannot be detected following TACE. Overall, the data suggested that this treatment method could improve the clinical outcome of patients with SHCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-020-0294-5","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T17:04:28Z","timestamp":1580403868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhaonan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-8619","authenticated-orcid":false,"given":"Xinwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanneng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"11","key":"294_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"294_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.21037\/hbsn.2016.05.03","volume":"5","author":"N Kamo","year":"2016","unstructured":"Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S. Liver transplantation for small hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2016;5(5):391\u20138.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"294_CR3","first-page":"658","volume":"43","author":"YB Zhu","year":"2014","unstructured":"Zhu YB, Xu X, Zheng SS. Association of microvascular invasion with recurrence and prognosis of patients with small hepatocellular carcinoma undergoing liver transplantation. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014;43(6):658\u201363.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"294_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","volume":"240","author":"V Mazzaferro","year":"2004","unstructured":"Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240(5):900\u20139.","journal-title":"Ann Surg"},{"issue":"1","key":"294_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-014-1708-1","volume":"141","author":"Q Feng","year":"2015","unstructured":"Feng Q, Chi Y, Liu Y, Zhang L, Liu Q. Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies. J Cancer Res Clin Oncol. 2015;141(1):1\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"294_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/bjs.9539","volume":"101","author":"G Huang","year":"2014","unstructured":"Huang G, Chen X, Lau WY, Shen F, Wang RY, Yuan SX, et al. Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas. Br J Surg. 2014;101(8):1006\u201315.","journal-title":"Br J Surg."},{"issue":"3","key":"294_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235\u201360.","journal-title":"Liver Cancer."},{"issue":"6","key":"294_CR8","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1007\/s00261-019-01943-2","volume":"44","author":"W Li","year":"2019","unstructured":"Li W, Ni CF. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma. Abdom Radiol (NY). 2019;44(6):2268\u201375.","journal-title":"Abdom Radiol (NY)."},{"issue":"11","key":"294_CR9","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/annonc\/mdg460","volume":"14","author":"TI Huo","year":"2003","unstructured":"Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, et al. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol. 2003;14(11):1648\u201353.","journal-title":"Ann Oncol."},{"issue":"12","key":"294_CR10","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1365-2036.2004.01996.x","volume":"19","author":"T Huo","year":"2004","unstructured":"Huo T, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, et al. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. Aliment Pharmacol Ther. 2004;19(12):1301\u20138.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"294_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/02656736.2014.999017","volume":"31","author":"H Huang","year":"2015","unstructured":"Huang H, Liang P, Yu XL, Cheng ZG, Han ZY, Yu J, et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia. 2015;31(1):40\u20137.","journal-title":"Int J Hyperthermia."},{"issue":"29","key":"294_CR12","doi-asserted-by":"publisher","first-page":"10174","DOI":"10.3748\/wjg.v20.i29.10174","volume":"20","author":"W Dong","year":"2014","unstructured":"Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20(29):10174\u201382.","journal-title":"World J Gastroenterol."},{"key":"294_CR13","first-page":"8619096","volume":"2019","author":"Z Xu","year":"2019","unstructured":"Xu Z, Xie H, Zhou L, Chen X, Zheng S. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma. Anal Cell Pathol (Amst). 2019;2019:8619096.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"8","key":"294_CR14","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.1007\/s13277-014-1976-z","volume":"35","author":"Z Liu","year":"2014","unstructured":"Liu Z, Gao F, Yang G, Singh S, Lu M, Zhang T, et al. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis. Tumour Biol. 2014;35(8):7407\u201313.","journal-title":"Tumour Biol."},{"issue":"1","key":"294_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/02656736.2016.1196830","volume":"33","author":"C Amabile","year":"2017","unstructured":"Amabile C, Ahmed M, Solbiati L, Meloni MF, Solbiati M, Cassarino S, et al. Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia. 2017;33(1):34\u201342.","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"294_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2214\/ajr.174.2.1740323","volume":"174","author":"SN Goldberg","year":"2000","unstructured":"Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174(2):323\u201331.","journal-title":"AJR Am J Roentgenol."},{"issue":"5","key":"294_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/02656731003717574","volume":"26","author":"FY Liu","year":"2010","unstructured":"Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia. 2010;26(5):448\u201355.","journal-title":"Int J Hyperthermia."},{"issue":"Suppl 1","key":"294_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000111718","volume":"72","author":"P Liang","year":"2007","unstructured":"Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72(Suppl 1):124\u201331.","journal-title":"Oncology."},{"issue":"1","key":"294_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1148\/radiol.2351031944","volume":"235","author":"P Liang","year":"2005","unstructured":"Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. RADIOLOGY. 2005;235(1):299\u2013307.","journal-title":"RADIOLOGY."},{"issue":"3","key":"294_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/02656736.2015.1127434","volume":"32","author":"A Facciorusso","year":"2016","unstructured":"Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Int J Hyperthermia. 2016;32(3):339\u201344.","journal-title":"Int J Hyperthermia."},{"issue":"6","key":"294_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3748\/wjg.15.748","volume":"15","author":"WZ Yang","year":"2009","unstructured":"Yang WZ, Jiang N, Huang N, Huang JY, Zheng QB, Shen Q. Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol. 2009;15(6):748\u201352.","journal-title":"World J Gastroenterol."},{"issue":"6","key":"294_CR22","first-page":"1245","volume":"89","author":"T Seki","year":"2000","unstructured":"Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer-Am Cancer Soc. 2000;89(6):1245\u201351.","journal-title":"Cancer-Am Cancer Soc."},{"issue":"11","key":"294_CR23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s00270-017-1736-8","volume":"40","author":"QF Chen","year":"2017","unstructured":"Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors &lt;\/=5 cm: A Propensity Analysis at a Single Center. Cardiovasc Intervent Radiol. 2017;40(11):1748\u201355.","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"3","key":"294_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/jgh.12088","volume":"28","author":"LF Xu","year":"2013","unstructured":"Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, et al. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol. 2013;28(3):456\u201363.","journal-title":"J Gastroenterol Hepatol."},{"issue":"26","key":"294_CR25","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.3748\/wjg.v19.i26.4192","volume":"19","author":"ZJ Wang","year":"2013","unstructured":"Wang ZJ, Wang MQ, Duan F, Song P, Liu FY, Chang ZF, et al. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas. World J Gastroenterol. 2013;19(26):4192\u20139.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"294_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.acra.2018.04.007","volume":"26","author":"H Yuan","year":"2019","unstructured":"Yuan H, Liu F, Li X, Guan Y, Wang M. Angio-CT-Guided Transarterial Chemoembolization Immediately in Combination with Radiofrequency Ablation for Large Hepatocellular Carcinoma. Acad Radiol. 2019;26(2):224\u201331.","journal-title":"Acad Radiol."},{"issue":"3","key":"294_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/SLA.0000000000002381","volume":"266","author":"VG Agopian","year":"2017","unstructured":"Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, et al. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg. 2017;266(3):525\u201335.","journal-title":"Ann Surg."},{"issue":"3","key":"294_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000453665","volume":"92","author":"K Kato","year":"2017","unstructured":"Kato K, Abe H, Ika M, Yonezawa T, Sato Y, Hanawa N, et al. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma. Oncology. 2017;92(3):142\u201352.","journal-title":"Oncology."},{"issue":"1","key":"294_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-018-0932-1","volume":"124","author":"H Yuan","year":"2019","unstructured":"Yuan H, Liu F, Li X, Guan Y, Wang M. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided radiofrequency ablation in the treatment of solitary large hepatocellular carcinoma. Radiol Med. 2019;124(1):1\u20137.","journal-title":"Radiol Med."},{"issue":"3","key":"294_CR30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.7314\/APJCP.2013.14.3.1649","volume":"14","author":"ZJ Wang","year":"2013","unstructured":"Wang ZJ, Wang MQ, Duan F, Song P, Liu FY, Wang Y, et al. Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14(3):1649\u201354.","journal-title":"Asian Pac J Cancer Prev."},{"key":"294_CR31","first-page":"321915466","volume":"12","author":"TQ Zhang","year":"2019","unstructured":"Zhang TQ, Huang ZM, Shen JX, Chen GQ, Shen LJ, Ai F, et al. Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma. Therap Adv Gastroenterol. 2019;12:321915466.","journal-title":"Therap Adv Gastroenterol."},{"issue":"1","key":"294_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jvir.2013.09.005","volume":"25","author":"A Andreano","year":"2014","unstructured":"Andreano A, Galimberti S, Franza E, Knavel EM, Sironi S, Lee FT, et al. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol. 2014;25(1):97\u2013105.","journal-title":"J Vasc Interv Radiol."}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-0294-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-020-0294-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-0294-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:32:05Z","timestamp":1611880325000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-0294-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-0294-5","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"2 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}